+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Pediatric Neuroblastoma Treatment Market Report 2025 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Vasculitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Vasculitis Treatment - Global Strategic Business Report

  • Report
  • May 2025
  • 183 Pages
  • Global
From
From
From
Urinary Incontinence - Pipeline Insight, 2025 - Product Thumbnail Image

Urinary Incontinence - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Myasthenia Gravis Treatment Market: Forecast and Trends - Product Thumbnail Image

Myasthenia Gravis Treatment Market: Forecast and Trends

  • Report
  • November 2023
  • 120 Pages
  • Global
From
From
From
From
Allergy Relieving Eye Drops Market 2024-2028 - Product Thumbnail Image

Allergy Relieving Eye Drops Market 2024-2028

  • Report
  • August 2024
  • 141 Pages
  • Global
From
Ovulation Inducing Drugs Market Report 2025 - Product Thumbnail Image

Ovulation Inducing Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Loading Indicator